274 related articles for article (PubMed ID: 32054489)
1. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
[TBL] [Abstract][Full Text] [Related]
2. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
3. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
[TBL] [Abstract][Full Text] [Related]
4. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
7. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
8. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
9. IGF1 regulates PKM2 function through Akt phosphorylation.
Salani B; Ravera S; Amaro A; Salis A; Passalacqua M; Millo E; Damonte G; Marini C; Pfeffer U; Sambuceti G; Cordera R; Maggi D
Cell Cycle; 2015; 14(10):1559-67. PubMed ID: 25790097
[TBL] [Abstract][Full Text] [Related]
10. C-MET-dependent signal transduction mediates retinoblastoma growth by regulating PKM2 nuclear translocation.
Dai H; Zeng W; Luo H
Cell Biochem Funct; 2020 Mar; 38(2):204-212. PubMed ID: 31729060
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.
Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG
Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102
[TBL] [Abstract][Full Text] [Related]
12. Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.
Hwang SR; Murga-Zamalloa C; Brown N; Basappa J; McDonnell SR; Mendoza-Reinoso V; Basrur V; Wilcox R; Elenitoba-Johnson K; Lim MS
Lab Invest; 2017 Aug; 97(8):962-970. PubMed ID: 28414323
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
14. 2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2.
Yoon YJ; Kim YH; Jin Y; Chi SW; Moon JH; Han DC; Kwon BM
Cancer Lett; 2018 Oct; 434():42-55. PubMed ID: 30009856
[TBL] [Abstract][Full Text] [Related]
15. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
[TBL] [Abstract][Full Text] [Related]
16. AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.
Park YS; Kim DJ; Koo H; Jang SH; You YM; Cho JH; Yang SJ; Yu ES; Jung Y; Lee DC; Kim JA; Park ZY; Park KC; Yeom YI
Oncotarget; 2016 Jul; 7(30):48155-48167. PubMed ID: 27340866
[TBL] [Abstract][Full Text] [Related]
17. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
[TBL] [Abstract][Full Text] [Related]
18. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect.
Gupta A; Ajith A; Singh S; Panday RK; Samaiya A; Shukla S
Cell Death Dis; 2018 Aug; 9(8):825. PubMed ID: 30068946
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
20. Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer.
Li Q; Zhang D; Chen X; He L; Li T; Xu X; Li M
Sci Rep; 2015 Nov; 5():16082. PubMed ID: 26542452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]